Afficher la couverture 'On the Hunt for Next-Generation Antimicrobial Agents: An Online Symposium Organized Jointly by the French Society for Medicinal Chemistry (Société de Chimie Thérapeutique) and the French Microbiology Society (Société Française de Microbiologie) on 9–10 December 2021 | Antraygues, Kevin' en grand format
/5

0 avis

On the Hunt for Next-Generation Antimicrobial Agents: An Online Symposium Organized Jointly by the French Society for Medicinal Chemistry (Société de Chimie Thérapeutique) and the French Microbiology Society (Société Française de Microbiologie) on 9–10 December 2021

Archive ouverte

Antraygues, Kevin | Compagne, Nina | Ruggieri, Francesca | Djaout, Kamel | Edoo, Zainab | Eveque, Maxime | Faïon, Léo | Gioia, Bruna | Tangara, Salia | Vieira da Cruz, Anais | Villemagne, Baptiste | Flipo, Marion | Baulard, Alain | Willand, Nicolas

Edité par CCSD ; MDPI -

International audience. The restrictions posed by the COVID-19 pandemic obliged the French Society for Medicinal Chemistry (Société de chimie thérapeutique) and the French Microbiology Society (Société Française de Microbiologie) to organize their joint autumn symposium (entitled “On the hunt for next-generation antimicrobial agents”) online on 9–10 December 2021. The meeting attracted more than 200 researchers from France and abroad with interests in drug discovery, antimicrobial resistance, medicinal chemistry, and related disciplines. This review summarizes the 13 invited keynote lectures. The symposium generated high-level scientific dialogue on the most recent advances in combating antimicrobial resistance. The University of Lille, the Institut Pasteur de Lille, the journal Pharmaceuticals, Oxeltis, and INCATE, sponsored the event.

Suggestions

Du même auteur

Antibiotics with novel mode of action as new weapons to fight antimicrobial resistance

Archive ouverte | Ruggieri, Francesca | CCSD

International audience. Antimicrobial resistance (AMR) is a major public health issue, causing 5 million deaths per year. Without any action plan, AMR will be in a near future the leading cause of death ahead of can...

Tricyclic SpiroLactams Kill Mycobacteria In Vitro and In Vivo by Inhibiting Type II NADH Dehydrogenases

Archive ouverte | Dam, Sushovan | CCSD

International audience. It is critical that novel classes of antituberculosis drugs are developed to combat the increasing burden of infections by multidrug-resistant strains. To identify such a novel class of antib...

Optimization of pyridylpiperazine-based inhibitors of the Escherichia coli AcrAB-TolC efflux pump

Archive ouverte | Compagne, Nina | CCSD

International audience. Multidrug–resistant Escherichia coli is a continuously growing worldwide public health problem, in which the well-known AcrAB-TolC tripartite RND efflux pump is a critical driver. We have pre...

Chargement des enrichissements...